{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:01:15Z","timestamp":1777507275716,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Fund for Distinguished Young Scholars","award":["81925001"],"award-info":[{"award-number":["81925001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>While <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (PA) colonization is linked to poor outcomes in bronchiectasis, emerging evidence suggests that microbial community collapse\u2014marked by diversity loss and depletion of commensal taxa\u2014may better reflect disease progression than pathogen load alone. This study investigates whether airway microbiota dysbiosis driven by PA colonization induces ecological fragility and evaluates the predictive utility of integrating microbial diversity indices with systemic inflammation markers to forecast 1-year acute exacerbation risk using interpretable machine learning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Bronchoalveolar lavage fluid (BALF) samples from 23 patients (8 PA-colonized, 15 non-colonized) underwent 16\u00a0S rRNA gene sequencing. Microbial diversity and taxonomic composition were analyzed. An eXtreme Gradient Boosting (XGBoost) model with SHapley Additive exPlanations (SHAP) analysis was constructed to assess exacerbation risk, focusing on microbial and inflammatory markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>PA-colonized patients (P1) exhibited significantly worse clinical severity than non-colonized patients (P2), with higher Bronchiectasis Severity Index scores (8.38 vs. 4.33, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), poorer quality-of-life (SGRQ: 35.75 vs. 22.79; CAT: 24.00 vs. 16.26, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), and elevated dyspnea (mMRC: 1.62 vs. 0.95, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). P1 also had more acute exacerbations annually (retrospective: 3.00 vs. 1.20; prospective: 3.75 vs. 0.80, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05\u20130.001). Notably, P1 exhibited significantly reduced alpha diversity compared to P2 (Shannon index: 1.96 vs. 3.47; Simpson index: 0.46 vs. 0.77, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Weighted UniFrac PCoA revealed distinct clustering between groups (R\u00b2=0.162, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The XGBoost model, integrating microbial taxa relative abundances, alpha diversity indices, and inflammatory markers demonstrated robust performance in predicting 1-year acute exacerbation risk (AUC\u2009=\u20090.85). SHAP analysis identified the microbial diversity, rather than <jats:italic>Pseudomona<\/jats:italic> abundance was the most influential predictor of exacerbation risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>PA colonization disrupts airway microbial diversity and outcompetes commensal species in bronchiectasis, yet our XGBoost model reveals that ecological resilience\u2014not pathogen load\u2014best predicts exacerbation risk when integrated with inflammatory markers. This paradigm shift from pathogen-centric to ecosystem-driven risk assessment provides an actionable framework for personalized management and antibiotic stewardship in chronic airway diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-025-03892-7","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:51:01Z","timestamp":1756723861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pseudomonas aeruginosa-driven airway dysbiosis and machine learning prediction of acute exacerbations in non-cystic fibrosis bronchiectasis: a microbial-inflammatory signature approach"],"prefix":"10.1186","volume":"25","author":[{"given":"Wen-Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"6","key":"3892_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"key":"3892_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0038-2024","author":"M Mac Aogain","year":"2024","unstructured":"Mac Aogain M, Dicker AJ, Mertsch P, Chotirmall SH. Infection and the microbiome in bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0038-2024.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"3892_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2019.07.010","volume":"26","author":"YH Chai","year":"2020","unstructured":"Chai YH, Xu JF. How does Pseudomonas aeruginosa affect the progression of bronchiectasis? Clin Microbiol Infect. 2020;26(3):313\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3892_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","volume":"27","author":"M Mac Aogain","year":"2021","unstructured":"Mac Aogain M, Narayana JK, Tiew PY, Ali N, Yong VFL, Jaggi TK, et al. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021;27(4):688\u201399.","journal-title":"Nat Med"},{"key":"3892_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03390-2020","author":"O Sibila","year":"2021","unstructured":"Sibila O. Reducing Pseudomonas sputum density in bronchiectasis. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.03390-2020.","journal-title":"Eur Respir J"},{"issue":"5","key":"3892_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3892_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijtb.2020.09.010","volume":"68","author":"A Deshmukh","year":"2021","unstructured":"Deshmukh A, Vadala R, Talwar D. Utility of bronchiectasis severity index (BSI) as prognostic tool in patients with post tubercular bronchiectasis: an experience from a tertiary care hospital in North India. Indian J Tuberc. 2021;68(2):261\u20135.","journal-title":"Indian J Tuberc"},{"issue":"11","key":"3892_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1164\/rccm.202303-0499OC","volume":"208","author":"H Choi","year":"2023","unstructured":"Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L, et al. Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study. Am J Respir Crit Care Med. 2023;208(11):1166\u201376.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3892_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","volume":"9","author":"AJ Dicker","year":"2021","unstructured":"Dicker AJ, Lonergan M, Keir HR, Smith AH, Pollock J, Finch S, et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021;9(8):885\u201396.","journal-title":"Lancet Respir Med"},{"key":"3892_CR10","doi-asserted-by":"publisher","unstructured":"Chalmers JD, Mall MA, Chotirmall SH, O\u2019Donnell AE, Flume PA, Hasegawa N et al. Targeting neutrophil Serine proteases in bronchiectasis. Eur Respir J. 2025;65(1): Article ID: 2401050. https:\/\/doi.org\/10.1183\/13993003.01050-2024.","DOI":"10.1183\/13993003.01050-2024"},{"issue":"1","key":"3892_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"3892_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jamacardio.2021.0122","volume":"6","author":"R Khera","year":"2021","unstructured":"Khera R, Haimovich J, Hurley NC, McNamara R, Spertus JA, Desai N, et al. Use of machine learning models to predict death after acute myocardial infarction. JAMA Cardiol. 2021;6(6):633\u201341.","journal-title":"JAMA Cardiol"},{"issue":"9","key":"3892_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3892_CR14","first-page":"CD012528","volume":"2","author":"C Kelly","year":"2018","unstructured":"Kelly C, Grundy S, Lynes D, Evans DJ, Gudur S, Milan SJ, et al. Self-management for bronchiectasis. Cochrane Database Syst Rev. 2018;2(2):CD012528.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"3892_CR15","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2010.136119","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur MC, Bilton D, Hill AT. British thoracic society bronchiectasis Non CFGG. British thoracic society guideline for Non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1\u201358.","journal-title":"Thorax"},{"issue":"1","key":"3892_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12931-022-02229-w","volume":"23","author":"WW Wang","year":"2022","unstructured":"Wang WW, Mao B, Liu Y, Gu SY, Lu HW, Bai JW, et al. Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis. Respir Res. 2022;23(1):317.","journal-title":"Respir Res"},{"issue":"1","key":"3892_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12967-022-03364-0","volume":"20","author":"S Yue","year":"2022","unstructured":"Yue S, Li S, Huang X, Liu J, Hou X, Zhao Y, et al. Machine learning for the prediction of acute kidney injury in patients with sepsis. J Transl Med. 2022;20(1):215.","journal-title":"J Transl Med"},{"issue":"10","key":"3892_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","volume":"187","author":"MM Tunney","year":"2013","unstructured":"Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013;187(10):1118\u201326.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3892_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","volume":"68","author":"GB Rogers","year":"2013","unstructured":"Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax. 2013;68(8):731\u20137.","journal-title":"Thorax"},{"issue":"1","key":"3892_CR20","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41598-019-42862-y","volume":"9","author":"TE Woo","year":"2019","unstructured":"Woo TE, Lim R, Heirali AA, Acosta N, Rabin HR, Mody CH, et al. A longitudinal characterization of the non-cystic fibrosis bronchiectasis airway microbiome. Sci Rep. 2019;9(1):6871.","journal-title":"Sci Rep"},{"issue":"12","key":"3892_CR21","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1128\/JB.01631-09","volume":"192","author":"S Periasamy","year":"2010","unstructured":"Periasamy S, Kolenbrander PE. Central role of the early colonizer Veillonella sp. in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel. J Bacteriol. 2010;192(12):2965\u201372.","journal-title":"J Bacteriol"},{"issue":"50","key":"3892_CR22","doi-asserted-by":"publisher","first-page":"15195","DOI":"10.1021\/acs.jafc.1c06029","volume":"69","author":"M Yu","year":"2021","unstructured":"Yu M, Meng T, He W, Huang H, Liu C, Fu X, et al. Dietary chito-oligosaccharides improve intestinal immunity via regulating microbiota and Th17\/Treg balance-related immune signaling in piglets challenged by enterotoxigenic E. coli. J Agric Food Chem. 2021;69(50):15195\u2013207.","journal-title":"J Agric Food Chem"},{"key":"3892_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jbiotec.2019.11.004","volume":"307","author":"U Sood","year":"2020","unstructured":"Sood U, Singh DN, Hira P, Lee JK, Kalia VC, Lal R, et al. Rapid and solitary production of mono-rhamnolipid biosurfactant and biofilm inhibiting pyocyanin by a taxonomic outlier Pseudomonas aeruginosa strain CR1. J Biotechnol. 2020;307:98\u2013106.","journal-title":"J Biotechnol"},{"issue":"9","key":"3892_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/thoraxjnl-2019-214187","volume":"75","author":"MT Nelson","year":"2020","unstructured":"Nelson MT, Wolter DJ, Eng A, Weiss EJ, Vo AT, Brittnacher MJ, et al. Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome. Thorax. 2020;75(9):780\u201390.","journal-title":"Thorax"},{"issue":"1","key":"3892_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","volume":"163","author":"WJ Guan","year":"2023","unstructured":"Guan WJ, Xu JF, Luo H, Xu XX, Song YL, Ma WL, et al. A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection. Chest. 2023;163(1):64\u201376.","journal-title":"Chest"},{"issue":"1","key":"3892_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12931-024-02835-w","volume":"25","author":"H Motta","year":"2024","unstructured":"Motta H, Reuwsaat JCV, Lopes FC, Viezzer G, Volpato FCZ, Barth AL, et al. Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respir Res. 2024;25(1):211.","journal-title":"Respir Res"},{"issue":"4","key":"3892_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1128\/CMR.00096-15","volume":"29","author":"BY Hong","year":"2016","unstructured":"Hong BY, Maulen NP, Adami AJ, Granados H, Balcells ME, Cervantes J. Microbiome changes during tuberculosis and antituberculous therapy. Clin Microbiol Rev. 2016;29(4):915\u201326.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"3892_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.chom.2023.04.018","volume":"31","author":"W Liang","year":"2023","unstructured":"Liang W, Yang Y, Gong S, Wei M, Ma Y, Feng R, et al. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host Microbe. 2023;31(6):1054\u2013e709.","journal-title":"Cell Host Microbe"},{"issue":"10","key":"3892_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1164\/rccm.202210-1865OC","volume":"208","author":"I Sulaiman","year":"2023","unstructured":"Sulaiman I, Wu BG, Chung M, Isaacs B, Tsay JJ, Holub M, et al. Lower airway dysbiosis augments lung inflammatory injury in Mild-to-Moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2023;208(10):1101\u201314.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03892-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03892-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03892-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:54:46Z","timestamp":1757465686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03892-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03892-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Shanghai Pulmonary Hospital, School of Medicine, Tongji University (approval number K19-144) and conducted in accordance with the Helsinki Declaration. Written informed consent was obtained from all participants prior to the collection of samples and clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}